Journal of the American Chemical Society
Page 4 of 5
Leonard, J.; Morphy, R.; Wales, M.; Perry, M.; Allen, R. A.; Gozzard,
ity of the coupling partners and step economy in this three-compo-
nent coupling reaction can compensate for these limitations. Addi-
tional studies aim to overcome the competitive Heck reaction via
exploration of different combinations of benzyl acrylates and chiral
phosphoric acids as this pathway is also sensitive to the identity of
these two species (Table S1).
N.; Hughes, B.; Higgs, G. Bioorganic Med. Chem. Lett. 2002, 12, 1451.
(c) Ohlstein, E. H.; Nambi, P.; Douglas, S. A; Edwards, R. M.; Gellai,
M.; Lago, A.; Leber, J. D.; Cousins, R. D.; Gao, A.; Frazee, J. S.;
Peishoff, C. E.; Bean, J. W.; Eggleston, D. S.; Elshourbagy, N. A.; Ku-
mar, C.; Lee, J. A.; Yue, T.-L.; Louden, C.; Brooks, D. P.; Weinstock,
J.; Feuerstein, G.; Poste, G.; Ruffolo, R. R.; Gleason, J. G.; Elliott, J.
D. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 8052. (d) Hyttel, J.; Larsen,
J. J. J. Neurochem. 1985, 44, 1615.
1
2
3
4
5
6
7
8
In conclusion, we have developed an enantioselective three-
component coupling reaction of benzyl acrylates, aryldiazonium
salts and arylboronic acids, providing a modular approach to the
synthesis of 1,1-diarylated products in high enantioselectivity. The
key to a highly selective process was realized by utilizing a chiral
anion phase-transfer strategy, wherein enantioselectivity was
closely tied to the identity of the CAPT catalyst. Additionally, er
values were surprisingly sensitive to the electronic and steric nature
as well as the position of substituents on the benzyl acrylate sub-
strate. We applied a multidimensional modeling technique to reveal
specific properties of the CAPT catalyst and the acrylate that may
be responsible for the observed range in enantioselectivity. These
results suggest that attractive noncovalent interactions, such as a π-
stacking interaction, between the two components are controlling
elements in the enantiodetermining step. Future studies include fur-
ther exploration of these putative interactions in order to understand
the origin of enantioselectivity and facilitate the improvement and
expansion of this and other reactions in development.
(3) Gligorich, K.; Vaden, R.; Shelton, D.; Wang, G.; Matsen, C.; Looper,
R.; Sigman, M.; Welm, B. Breast Cancer Res. 2013, 15, R58.
(4) (a) Liao, L.; Jana, R.; Urkalan, K. B.; Sigman, M. S. J. Am. Chem. Soc.
2011, 133, 5784; (b) Saini, V.; Sigman, M. S. J. Am. Chem. Soc. 2012,
134, 11372 (c) Saini, V.; Liao, L.; Wang, Q.; Jana, R.; Sigman, M. S.
Org. Lett. 2013, 15, 5008.
(5) (a) Nelson, H. M.; Williams, B. D.; Miró, J.; Toste, F. D. J. Am. Chem.
Soc. 2015, 137, 3213. For reviews on chiral ion pairs used in catalysis,
see: (b) Phipps, R. J.; Hamilton, G. L.; Toste, F. D. Nature Chem. 2012,
4, 603. (c) Brak, K.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2013, 52,
534.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(6) (a) Zi, W.; Wang, Y.-M.; Toste, F. D. J. Am. Chem. Soc. 2014, 136,
12864. (b) Neel, A. J.; Milo, A.; Sigman, M. S.; Toste, F. D. J. Am.
Chem. Soc. 2016, 138, 3863.
(7) For examples of catalytic synthetic methods toward enantioenriched
3,3-diaryl propanoates, see: (a) Tolstoy, P.; Engman, M.; Paptchikhine,
A.; Bergquist, J.; Church, T. L.; Leung, A. W.-M.; Andersson, P. G. J.
Am. Chem. Soc. 2009, 131, 8855; (b) Taylor, J. G.; Correia, C. R. D. J.
Org. Chem. 2011, 76, 857; (c) Itoh, K.; Tsuruta, A.; Ito, J.-i.; Yama-
moto, Y.; Nishiyama, H. J. Org. Chem. 2012, 77, 10914; (d) Sakuma,
S.; Sakai, M.; Itooka, R.; Miyaura, N. J. Org. Chem. 2000, 65, 5951;
(e) Paquin, J.-F.; Stephenson, C. R. J.; Defieber, C.; Carreira, E. M.
Org. Lett. 2005, 7, 3821; (f) Nishikata, T.; Kiyomura, S.; Yamamoto,
Y.; Miyaura, N. Synlett 2008, 2487; (g) Luo, Y.; Carnell, A. J. Angew.
Chem. Int. Ed. 2010, 49, 2750; (h) Xue, F.; Wang, D.; Li, X.; Wan, B.
Org. Biomol. Chem. 2013, 11, 7893; (i) Miyamura, H.; Suzuki, A.; Ya-
sukawa, T.; Kobayashi, S. Adv. Synth. Catal. 2015, 357, 3815; (j) Xu,
B.; Li, M.-L.; Zuo, X.-D.; Zhu, S.-F.; Zhou, Q.-L. J. Am. Chem. Soc.
2015, 137, 8700.
ASSOCIATED CONTENT
Experimental procedures and modeling and characterization data
can be found in the supporting information. This material is avail-
AUTHOR INFORMATION
(8) Sigman, M. S.; Harper, K. C.; Bess, E. N.; Milo, A. Acc. Chem. Res.
2016, 49, 1292.
(9) For structure-function analysis of BINOL-derived phosphoric acids,
see: (a) Reid, J. P.; Goodman, J. M. J. Am. Chem. Soc. 2016, 138, 7910.
(b) Reid, J. P.; Simón, L; Goodman, J. M. Acc. Chem. Res. 2016, 49,
1029.
(10)(a) Verloop, A. In Drug Design; Ariens, E. J., Ed.; Academic Press:
Waltham, MA, 1976; Vol. III, p 133. (b) Verloop, A.; Tipker, J. Phar-
macochem. Libr. 1977, 2, 63. (c) Verloop, A.; Tipker, J. Pharmaco-
chem. Libr. 1987, 10, 97. (d) Harper, K. C.; Bess, E. N.; Sigman, M. S.
Nature Chem. 2012, 4, 366.
(11)For substrates 1d, 1k, and 1l the NBO charge of the 2-hydrogen only
was considered. For 1e, the average NBO charge of the methyl hydro-
gens were included since these are most accessible compared to the
carbons. Thus, these hydrogens would likely represent a potential site
for a noncovalent interaction to occur.
(12)Hydrogen-bonding interactions of highly polar ortho-C-H bonds in 3,5-
bis(CF3)phenyl group in thiourea catalysts are known to be involved in
a variety of organocatalytic reactions. For selected examples, see: (a)
Okino, T., Yasutaka, H., Furukawa, T., Xu, X. Takemoto, Y. J. Am.
Chem. Soc. 2005, 127, 119; (b) Berkessel, A.; Cleemann, F.; Mukher-
jee, S.; Müller, T. N.; Lex, J. Angew. Chem. Int. Ed. 2005, 44, 807; (c)
Tan, B.; Lu, Y.; Zeng, X.; Chua, P. J.; Zhong, G. Org. Lett. 2010, 12,
2682; (d) Zhang, Z.; Lippert, K. M.; Hausmann, H.; Kotke, M.;
Schreiner, P. R. J. Org. Chem. 2011, 76, 9764; (e) Lippert, K. M.; Hof,
K.; Gerbig, D.; Ley, D.; Hausmann, H.; Guenther, S.; Schreiner, P. R.
Eur. J. Org. Chem. 2012, 30, 5919.
(13)Milo, A.; Bess, E. N.; Sigman, M. S. Nature 2014, 507, 210.
(14)Chen, Z.-M.; Hilton, M. J.; Sigman, M. S. J. Am. Chem. Soc. 2016, 138,
11461.
(15)(a) Krenske, E. H.; Houk, K. N. Acc. Chem. Res. 2013, 46, 979. (b)
Sherrill, C. D. Acc. Chem. Res. 2013, 46, 1020. (c) Wheeler, S. E. Acc.
Chem. Res. 2013, 46, 1029.
*sigman@chem.utah.edu
⁑E.Y. and M.J.H. contributed equally.
‡Department of Chemistry, Graduate School of Science, Kyushu
University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
‖Novartis Institute for Biomedical Research, Cambridge, Massa-
chusetts 02139, United States
The authors declare no competing financial interests.
ACKNOWLEDGMENTS
The synthetic aspects were supported by National Institute of
Health (R01GM063540), and the modeling was supported by NSF
(CHE-1361296). E.Y. was supported by a Grant-in-Aid for JSPS
Fellows (JSPS KAKENHI, grant number: 26·2447). M.O. thanks
the Ermenegildo Zegna Group for a post-doctoral fellowship. We
gratefully acknowledge the Center for High Performance Compu-
ting (CHPC) at the University of Utah. We would like to thank Anat
Milo and Andrew J. Neel for insightful discussions and sharing
CAPT catalysts with us.
REFERENCES
(1) For reviews, see: (a) Jensen, K. H.; Sigman, M. S. Org. Biomol. Chem.
2008, 6, 4083; (b) McDonald, R. I.; Liu, G.; Stahl, S. S. Chem. Rev.
2011, 111, 2981.
(2) For recent reviews, see: (a) Ameen, D.; Snape, T. J. Med. Chem. Com-
mun. 2013, 4, 893. For examples, see: (b) Alexander, R. P.; Warrellow,
G. J.; Eaton, M. A. W.; Boyd, E. C.; Head, J. C.; Porter, J. R.; Brown,
J. A.; Reuberson, J. T.; Hutchinson, B.; Turner, P.; Boyce, B.; Barnes,
D.; Mason, B.; Cannell, A.; Taylor, R. J.; Zomaya, A.; Millican, A.;
(16)As these substrates demonstrated the same selectivity with the model
system, 1q was chosen over 1r due to lower cost.
ACS Paragon Plus Environment